Cognition Operating Income from 2010 to 2025

CGTX Stock  USD 0.45  0.01  2.17%   
Cognition Therapeutics Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -47.9 M in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Cognition Therapeutics generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2010-12-31
Previous Quarter
-45.7 M
Current Value
-47.9 M
Quarterly Volatility
13 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cognition Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cognition Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 215.5 K, Interest Expense of 23.1 K or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.14. Cognition financial statements analysis is a perfect complement when working with Cognition Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Cognition Therapeutics Correlation against competitors.
For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.

Latest Cognition Therapeutics' Operating Income Growth Pattern

Below is the plot of the Operating Income of Cognition Therapeutics over the last few years. Operating Income is the amount of profit realized from Cognition Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cognition Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Cognition Therapeutics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cognition Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

Cognition Operating Income Regression Statistics

Arithmetic Mean(25,760,986)
Geometric Mean23,351,813
Coefficient Of Variation(50.45)
Mean Deviation10,956,731
Median(17,831,000)
Standard Deviation12,996,431
Sample Variance168.9T
Range33.3M
R-Value(0.80)
Mean Square Error66T
R-Squared0.64
Significance0.0002
Slope(2,176,129)
Total Sum of Squares2533.6T

Cognition Operating Income History

2025-47.9 M
2024-45.7 M
2023-50.7 M
2022-43.6 M
2021-28.6 M
2020-17.4 M

Other Fundumenentals of Cognition Therapeutics

Cognition Therapeutics Operating Income component correlations

0.980.960.23-0.99-0.820.920.82-0.58-0.960.981.00.90.990.730.9-0.84-0.36-0.48
0.980.990.35-0.98-0.90.940.81-0.62-0.991.00.980.930.970.730.93-0.83-0.48-0.61
0.960.990.4-0.95-0.940.950.82-0.66-1.00.990.960.950.930.750.95-0.83-0.55-0.69
0.230.350.4-0.19-0.530.370.18-0.08-0.430.330.210.540.140.020.540.1-0.38-0.58
-0.99-0.98-0.95-0.190.81-0.91-0.780.560.95-0.98-1.0-0.87-0.99-0.7-0.870.830.340.45
-0.82-0.9-0.94-0.530.81-0.85-0.830.760.94-0.9-0.82-0.94-0.77-0.77-0.940.750.610.82
0.920.940.950.37-0.91-0.850.79-0.66-0.950.940.920.930.890.760.93-0.78-0.46-0.67
0.820.810.820.18-0.78-0.830.79-0.89-0.80.830.820.870.790.950.87-0.87-0.37-0.57
-0.58-0.62-0.66-0.080.560.76-0.66-0.890.64-0.63-0.59-0.7-0.55-0.97-0.70.820.470.69
-0.96-0.99-1.0-0.430.950.94-0.95-0.80.64-0.99-0.95-0.95-0.93-0.72-0.950.80.530.68
0.981.00.990.33-0.98-0.90.940.83-0.63-0.990.980.930.970.740.93-0.84-0.48-0.61
1.00.980.960.21-1.0-0.820.920.82-0.59-0.950.980.891.00.730.89-0.85-0.36-0.47
0.90.930.950.54-0.87-0.940.930.87-0.7-0.950.930.890.850.771.0-0.72-0.42-0.68
0.990.970.930.14-0.99-0.770.890.79-0.55-0.930.971.00.850.70.85-0.85-0.33-0.41
0.730.730.750.02-0.7-0.770.760.95-0.97-0.720.740.730.770.70.77-0.9-0.39-0.6
0.90.930.950.54-0.87-0.940.930.87-0.7-0.950.930.891.00.850.77-0.72-0.42-0.68
-0.84-0.83-0.830.10.830.75-0.78-0.870.820.8-0.84-0.85-0.72-0.85-0.9-0.720.520.55
-0.36-0.48-0.55-0.380.340.61-0.46-0.370.470.53-0.48-0.36-0.42-0.33-0.39-0.420.520.88
-0.48-0.61-0.69-0.580.450.82-0.67-0.570.690.68-0.61-0.47-0.68-0.41-0.6-0.680.550.88
Click cells to compare fundamentals

About Cognition Therapeutics Financial Statements

Cognition Therapeutics investors use historical fundamental indicators, such as Cognition Therapeutics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cognition Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Income-45.7 M-47.9 M
Non Operating Income Net Other-31.5 K-33.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.